Abstract
Medical and health care applications of nanotechnology have increasingly attracted research and innovation attention. Nano-biomedical science (NBMS) is a term we use to define this emerging domain. As China is one of the leading countries in nanotechnology, but lacks a long history as a biosciences leader, this paper explores the competitive positioning of China in the development of NBMS. Specifically, this paper profiles the research patterns of Chinese NBMS in comparison with the four other largest countries in NBMS, using bibliometric techniques. The results indicate that China is a leader in NBMS, leveraging its strengths in chemistry and physics in the broader nanotechnology domain. However, China's relative weakness in traditional biomedical disciplines, and its lack of presence in highly influential global journals, could prove to be limiting factors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
